Oruka Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Oruka Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2013 to Q3 2024.
  • Oruka Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Oruka Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Oruka Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Oruka Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $0 Sep 30, 2024 10-Q 2024-11-13
Q2 2020 -$9K +$18K +66.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q4 2019 -$167K -$16K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$42K -$11K -35.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 -$27K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$82K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q3 2018 -$31K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q3 2014 $0 $0 Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-12
Q3 2013 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.